MNLO Insider Trading Activity and SEC Form 4 Filings
MNLO insider trading summary
No open-market insider purchases or sales of Menlo Therapeutics Inc. (MNLO) have been reported on SEC Form 4 in the past 12 months.
Latest MNLO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 9, 2020 | Joseph Edelman | Director | Buy | $5.0M (2,702,702 @ $1.85) |
| Jun 9, 2020 | Perceptive Life Sciences Master Fund Ltd | 10% Owner | Buy | $5.0M (2,702,702 @ $1.85) |
| Jun 9, 2020 | Perceptive Advisors LLC | 10% Owner | Buy | $5.0M (2,702,702 @ $1.85) |
| Jul 24, 2018 | David J Collier | Insider | Sell | $96K (12,500 @ $7.65) |
| Jul 24, 2018 | Presidio Partners 2007 (Parallel), L.P. | Insider | Sell | $3.7M (487,500 @ $7.65) |
| Jul 24, 2018 | Presidio Partners 2007, L.P. | Insider | Sell | $96K (12,500 @ $7.65) |
| Jul 24, 2018 | Presidio Partners 2007 GP, L.P. | Insider | Sell | $3.7M (487,500 @ $7.65) |
| Jul 24, 2018 | Faysal A. Sohail | Insider | Sell | $3.7M (487,500 @ $7.65) |
| Jul 24, 2018 | Presidio Partners 2007, L.P. | Insider | Sell | $3.7M (487,500 @ $7.65) |
| Jul 24, 2018 | David J Collier | Insider | Sell | $3.7M (487,500 @ $7.65) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.